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Background: Rhinovirus infections are the most common cause of asthma exacerbations. The complex responses
by airway epithelium to rhinovirus can be captured by gene expression profiling. We hypothesized that: a) upper
and lower airway epithelium exhibit differential responses to double-stranded RNA (dsRNA), and b) that this is
modulated by the presence of asthma and allergic rhinitis.
Objectives: Identification of dsRNA-induced gene expression profiles of primary nasal and bronchial epithelial
cells from the same individuals and examining the impact of allergic rhinitis with and without concomitant allergic
asthma on expression profiles.
Methods: This study had a cross-sectional design including 18 subjects: 6 patients with allergic asthma with
concomitant rhinitis, 6 patients with allergic rhinitis, and 6 healthy controls. Comparing 6 subjects per group,
the estimated false discovery rate was approximately 5%. RNA was extracted from isolated and cultured primary
epithelial cells from nasal biopsies and bronchial brushings stimulated with dsRNA (poly(I:C)), and analyzed by
microarray (Affymetrix U133+ PM Genechip Array). Data were analysed using R and the Bioconductor Limma
package. Overrepresentation of gene ontology groups were captured by GeneSpring GX12.
Results: In total, 17 subjects completed the study successfully (6 allergic asthma with rhinitis, 5 allergic rhinitis, 6
healthy controls). dsRNA-stimulated upper and lower airway epithelium from asthma patients demonstrated significantly
fewer induced genes, exhibiting reduced down-regulation of mitochondrial genes. The majority of genes related to
viral responses appeared to be similarly induced in upper and lower airways in all groups. However, the induction of
several interferon-related genes (IRF3, IFNAR1, IFNB1, IFNGR1, IL28B) was impaired in patients with asthma.
Conclusions: dsRNA differentially changes transcriptional profiles of primary nasal and bronchial epithelial cells from
patients with allergic rhinitis with or without asthma and controls. Our data suggest that respiratory viruses affect
mitochondrial genes, and we identified disease-specific genes that provide potential targets for drug development.
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Viral respiratory tract infections are the most common
cause of asthma exacerbations [1], with rhinovirus (RV)
being the most prominent virus involved. Patients with
asthma are not at increased risk of a viral infection as
compared to healthy controls, but in case of an upper
respiratory infection they are more prone to develop a
lower respiratory tract infection with more severe
symptoms [2]. This suggests that host characteristics
are contributing to the clinical responses to virus in-
fections in asthma.
The majority of patients with asthma is sensitized to
environmental allergens, which is associated with allergic
airways inflammation [3]. There is increasing evidence of
interaction between viral infection and allergic sensiti-
zation, with increased risk for a more severe exacerbation
if patients with asthma are atopic [4]. Since asthma and
rhinitis co-exist to variable degrees [5], the host character-
istics in upper and lower airways when encountering a
respiratory virus are likely to vary to a similar extent. In
order to develop effective interventions for the prophylaxis
and treatment of virus-induced exacerbations in asthma,
it is mandatory to map the responses of both upper
and lower airways to respiratory viruses in patients with
asthma and/or rhinitis.
The upper and lower airway epithelial layer is con-
stantly exposed to viruses, bacteria and allergens, and
represents the first line of defence. Experiments with
nasal and bronchial epithelial cells from the same indi-
viduals suggested greater susceptibility of the lower
airways to RV because of differences in electrical re-
sistance and viral replication between upper and lower
airway epithelium, though no differences were observed
between asthma and healthy controls [6]. However, there
is increasing evidence that pre-existing asthma affects
epithelial cytokine responses to RV, such as impaired
interferon (IFN) production and differences in expression
of genes involved in immune response and airway re-
modelling [7-9]. Collectively, these studies suggest that
the complex role of the airway epithelium in response
to viruses is affected by asthma- and allergy-related
changes in gene expression.
Double-stranded RNA (dsRNA) is produced during
RV replication and is an important stimulus of the host
immune response [10]. Therefore, we hypothesized a) that
upper and lower airway epithelium exhibit differential re-
sponses to dsRNA infection and b) that this is modulated
by the presence of asthma and allergic rhinitis. To that
end, we aimed to compare dsRNA-induced gene expres-
sion profiles of cultured primary nasal and bronchial
epithelial cells obtained from patients with asthma with
concomitant allergic rhinitis, patients with allergic rhinitis
alone, and healthy controls. The observed gene-expression
profiles can be used to delineate the critical pathwaysthat are operative in epithelial cells after virus infection
in patients with and without pre-existing airways disease.
Methods
Subjects
In total, 18 subjects (>18 y) were recruited for this study,
which is part of a larger project [11]. The subjects com-
prised of three groups: 1) 6 subjects with allergic asthma
with concomitant allergic rhinitis, 2) 6 subjects with
allergic rhinitis, and 3) 6 healthy controls. Patients with
asthma had episodic chest symptoms, controlled or partly
controlled disease according to GINA-criteria [12] with
airway hyperresponsiveness (PC20 methacholine ≤ 8 mg/mL)
according to the standardized tidal volume method [13].
All subjects with allergic rhinitis had persistent, moderate
to severe disease according to ARIA-criteria [14] with
nasal symptoms for more than 4 days a week during
more than 4 consecutive weeks. Atopic status was based
on the presence of at least one positive skin prick test
response (>3 mm wheal) to common allergens. Subjects
had refrained from using any medication for their
asthma, rhinitis or allergy in the four weeks prior to taking
biopsies and brushings. Healthy controls had normal
spirometric values without airway hyperresponsiveness
(PC20 > 8 mg/mL), did not have a history of lung disease
and were not atopic.
All subjects were non-smokers or ex-smokers (≥5 pack
years). Subjects had not smoked within 12 months prior
to the study and they did not have any signs of a respira-
tory infection at the time of study visits. In the case of a
respiratory infection, a 6-week recovery period was taken
into account.
The study was approved by the hospital Medical Ethics
Committee of the Academic Medical Centre in Amsterdam,
and the study was registered in the Netherlands trial register
(www.trialregister.nl) with identifier NTR2125. All patients
gave written informed consent.
Design
This cross-sectional study consisted of two study visits.
At least 14 days after the screening visit for checking
inclusion and exclusion criteria, a fiberoptic bronchoscopy
was performed during which 4 bronchial brushings were
taken. Local anaesthesia of the larynx and lower airways
was achieved using 1% lignocaine. Subsequently, 4 nasal
biopsies were taken from the lower edge of the inferior
turbinate. Local anaesthesia was achieved by application of
adrenalin and cocaine under the inferior turbinate without
touching the biopsy site.
Poly(I:C) stimulation of cultured primary epithelial cells
Epithelial cells were isolated from bronchial brushings
and nasal biopsies as previously described [11]. The cells
were cultured to 80% confluence and pre-incubated with




Female gender (n) 14




‡Geometric Mean (Geometric Standard Deviation).
**Only from patients with both allergic asthma and rhinitis (none of the
healthy controls and only 1 out of 5 patients with rhinitis had a drop of 20%
in FEV1 at the highest concentration of methacholine-bromide 19.6 mg/ml).
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bation medium was removed and cells were exposed to
BEBM containing 20 μg/ml Poly(I:C), a synthetic dsRNA,
or with BEBM alone (control condition). RNA was extracted
from the cells following 24 hours of stimulation. For a
detailed description of the primary epithelial cell culture
and RNA extraction, see Additional file 1: Methods of the
online supplement.
Analysis and statistics
Microarray analysis was done by previously published
method [11]. In short, Human Genome U133+ PM Gen-
echip Array (Affymetrix inc., Santa Clara, CA, USA) was
used for microarray analysis of genes. Next, Affymetrix
Expression Console was used to analyze the array images
using the robust multichip analysis (RMA) algorithm.
Normalized data were further analysed using R (version
2.15) and the Bioconductor Limma package [15]. Differ-
ential gene expression was measured by empirical Bayes
t-statistics and p-values were adjusted for false discovery
rate correction [16]. The full microarray data was uploaded
to the Gene Expression Omnibus (GEO) with accession
number GSE51392.
GeneSpring GX12 (Agilent Technologies, Amstelveen,
The Netherlands) was used for Gene ontology (GO) ana-
lysis. To investigate the overrepresentation of gene ontology
groups we used the p-value adjusted for multiple testing
by Benjamini-Yekutieli [17] (p-value <0.01). To enable val-
idation of the microarray experiment changes in gene
expression after poly(I:C) stimulation of nine genes were
measured by independent real time PCR on the same start-
ing material used for the microarray analysis (Additional
file 1: Methods of the online supplement).
Sample size estimation was performed by a validated
algorithm for microarray studies as published previously
by our group [18], using data from two studies from
others and ourselves [19,20]. This analysis showed that the
present study had a False Discovery Rate of approximately
5% for detecting at least a 1.5-fold difference in gene
expression when comparing three groups of 6 subjects
at a significance level of 0.0001,
Results
The results of the validation by independent real time
PCR are presented in Additional file 1: Table S1 and
Additional file 2: Figure S1 of the online supplement.
Poly(I:C)-induced changes in airway epithelial cells
Sufficient RNA for gene expression profiling was obtained
from both nasal and bronchial epithelium of 6 healthy
controls, 5 patients with allergic rhinitis (1 patient was
excluded because of insufficient RNA in the nasal sample)
and 6 patients with both allergic rhinitis and allergic
asthma. The baseline characteristics of the subjectsincluded in the study are shown in Table 1 [11]. There
were no differences between the groups in age and spir-
ometry (p = 0.4 and p = 0.3, respectively). As expected,
PC20 was significantly lower in the patients with both
asthma and rhinitis as compared to those with rhinitis
alone and the controls. None of the healthy controls and
only 1 out of 5 patients with rhinitis had a drop of 20%
in FEV1 at the highest concentration of methacholine-
bromide 19.6 mg/ml.
Overall, a strong response was observed after stimula-
tion of the airway epithelial cells with poly(I:C). Using a
cut-off of p < 0.05 (adjusted for multiple testing), 10163
and 8342 genes were significantly induced in the healthy
upper and lower airway epithelium respectively, 9353 and
5190 genes in patients with allergic rhinitis, and 4919 and
5810 genes in patients with both asthma and allergic rhin-
itis (Additional file 1: Table S2 of the online supplement).
The majority of the most highly up-regulated genes
were interferon-related genes (CCL3, CCL4, CCL5, RSAD2,
OAS1, OASL, MX1, MX2, IFI6, IFIT1, IFIT3, IFI44, IFI44L,
CXCL10, CXCL11, TNFAIP6), which were induced in both
upper and lower airways in all subjects (Tables 2 and 3).
Functional characterization
It appeared that ~40% of the poly(I:C)-induced genes
was altered in both upper and lower airways in all 3
subject-groups (see Figure 1A and 1B). When studying the
functional characterization of these genes, many compar-
able GO-classes were significantly enriched in the upper
and lower airways, e.g. response to virus, apoptotic process,
antigen processing and presentation of peptide antigen via
MHC class I, and regulation of I-κB/NF-κB. The majority
of genes related to response to virus were induced in all
groups in the same direction (up- or down-regulated)
(Additional file 1: Table S3A and S3B of the online sup-
plement). Among the genes assigned to this GO-class
were those involved in TLR3-signaling (TLR3, TICAM,
TBK1, MYD88, IRAK3), interferons (IFNB1, IFNE, IFNK),
various interferon receptors and interferon-induced
proteins, cytokines (IL12A, IL23A, IL6) and particular
Table 2 Most highly up-regulated genes in the
upper airways
Healthy Allergic rhinitis Asthma
Gene ID FC adj.P.Val FC adj.P.Val FC adj.P.Val
CCL5 517.58 2.27E-06 717.90 1.11E-06 148.81 2.63E-02
RSAD2 260.58 6.48E-06 638.34 9.05E-07 98.63 2.63E-02
CMPK2 151.01 5.93E-05 469.49 4.62E-08 81.61 2.63E-02
OASL 256.41 1.48E-06 442.40 9.31E-08 93.45 2.63E-02
CCL3 277.19 3.04E-06 334.76 2.77E-06 45.69 2.78E-02
C4orf7 249.61 3.42E-07 319.09 3.92E-06 31.69 3.62E-02
MX2 115.45 3.43E-05 287.26 8.56E-08 72.32 2.63E-02
CCL4 255.13 2.38E-06 243.83 6.17E-06 39.32 2.82E-02
IFI44L 89.69 1.32E-04 240.00 5.17E-07 58.14 2.82E-02
APOBEC3A 224.06 6.80E-08 235.49 9.36E-07 40.77 2.81E-02
CXCL11 104.60 3.78E-06 189.03 2.90E-06 70.87 2.63E-02
CXCL10 74.79 3.67E-05 175.30 1.38E-06 72.35 2.63E-02
DEFB4A 169.21 2.86E-07 165.40 4.47E-06 51.52 3.06E-02
ESM1 109.38 7.55E-07 166.63 2.77E-06 34.37 2.78E-02
IFI44 64.88 1.56E-04 164.77 2.77E-06 42.51 3.06E-02
OAS1 73.40 3.58E-05 160.01 9.36E-07 38.28 2.79E-02
IFIT1 57.77 4.51E-04 150.43 2.08E-05 40.36 2.81E-02
IFIT3 84.45 2.91E-05 149.76 2.16E-06 41.00 2.63E-02
LAMP3 88.39 1.71E-05 137.82 5.31E-06 29.48 2.75E-02
TNFAIP6 137.00 4.06E-07 102.91 3.25E-05 27.28 3.28E-02
FC = fold change; adj.P.Val = p-value adjusted for multiple testing.
Table 3 Most highly up-regulated genes in the
lower airways
Healthy Allergic rhinitis Asthma
Gene ID FC adj.P.Val FC adj.P.Val FC adj.P.Val
CCL5 736.54 6.09E-08 322.77 1.61E-05 231.87 9.60E-03
CMPK2 395.26 2.56E-08 360.62 6.91E-06 164.40 8.69E-03
RSAD2 363.02 1.47E-07 304.55 6.91E-06 167.47 9.76E-03
CXCL11 315.72 1.08E-07 109.20 1.58E-04 156.95 8.45E-03
IFIT1 307.08 9.93E-08 281.31 2.49E-05 161.84 1.05E-02
IFI44L 274.95 2.91E-08 211.91 1.08E-05 113.56 9.51E-03
CXCL10 263.55 2.97E-06 121.34 5.72E-04 88.92 1.09E-02
OASL 241.59 6.78E-08 138.85 5.11E-05 160.96 8.11E-03
IFI44 236.92 4.06E-09 70.93 1.67E-05 104.82 9.45E-03
MX2 201.46 2.56E-08 163.72 1.64E-05 96.81 8.67E-03
MX1 140.44 1.43E-07 175.11 1.67E-05 67.81 9.45E-03
IFI6 165.88 5.52E-10 123.34 1.24E-05 77.06 9.76E-03
DEFB4A 31.48 3.94E-04 137.90 2.06E-04 25.92 1.11E-02
LAMP3 131.90 2.15E-06 86.23 2.50E-04 50.68 1.39E-02
XAF1 110.43 6.45E-08 98.06 1.67E-05 61.68 7.99E-03
OAS1 109.84 1.13E-07 86.84 5.10E-05 47.06 1.05E-02
APOBEC3A 101.03 3.84E-07 86.19 8.06E-04 74.29 7.44E-03
IFIT3 94.85 9.47E-08 88.51 5.73E-05 56.72 8.56E-03
CCL4 83.19 2.22E-04 20.90 2.27E-02 35.57 1.25E-02
CCL3 69.05 7.38E-04 17.00 4.78E-02 35.62 1.27E-02
FC = fold change; adj.P.Val = p-value adjusted for multiple testing.
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IL29), chemokines (CCL22, CCL4, CCL5), and transcrip-
tion factors (IRF3, IRF7, IRF9, RELA, FOSL1).
Upper and lower airways
There were between-group differences in genes related
to GO-class response to virus. Among the genes that
were induced in all subjects except for patients with
asthma were interferon involved genes (IL28B, IFNAR1),
CCL22, and FOSL1 with respect to the upper airways,
and several interferon involved genes (IRF3, IFNAR1,
IFNB1, IFNGR1, IL28B) in the lower airways.
The upper airways of patients with asthma with con-
comitant allergic rhinitis demonstrated significantly fewer
poly(I:C)-induced genes. In total, 57% of the induced
genes was altered exclusively in the upper airways of either
healthy subjects or allergic rhinitis patients and not in the
upper airways of patients with asthma. Among these
genes many GO classes were significantly overrepresented,
amongst which many genes were assigned to metabolic
process, mitochondrion and electron transport chain. Up to
2000 genes were assigned to metabolic process of which
347 genes overlap with class mitochondrion (Additional
file 1: Table S4 of the online supplement). These mito-chondrial genes were mostly down-regulated. The latter
class overlaps with genes assigned to the class electron
transport chain, including several NADH dehydrogenase
subcomplexes.
With respect to genes induced in the lower airways,
significantly enriched GO-glasses emerged among genes
exclusively induced in the lower airways of healthy sub-
jects, including metabolic process, nucleus and mitochon-
drion. Among these genes, 915 genes were assigned to
the GO-class metabolic process, of which 616 genes
match with class nucleus and 191 with class mitochondrion
(Additional file 1: Table S5 of the online supplement).
Along with the upper airways, the GO-class mitochondrion
was overrepresented among genes induced in the lower
airways of both healthy controls and allergic rhinitis
patients (Additional file 1: Table S6 of the online sup-
plement). In addition, these mitochondrial genes were
primarily down-regulated.
Disease-specific gene expression induction
We identified genes that were exclusively differentially
expressed in patients with asthma and/or allergic rhinitis.
We limited to genes that were up- or down-regulated by
more than threefold (at least in one of the patient-groups)
Figure 1 Venn-diagrams of up- and down-regulated genes. A. Venn-diagram of genes up- or down-regulated in the upper airways. B. Venn
diagram of genes up- or down-regulated in the lower airways.
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BBS1, nebulette (NEBL), nucleoside diphosphate kinase
(NME7), the ubiquitous protein AHNAK, the calcium-
binding S100A7A, myosin light chain kinase (MYLK),
the cornulin gene (CRNN), filaggrin (FLG), complement
factor B (CFB), bone morphogenetic protein 6 (BMP6),
adaptor protein SH3KBP1, endoplasmatic reticulum-
associated aminopeptidase 1 (ERAP1), and lysosome-
associated membrane protein 2 (LAMP2).Discussion
This study shows the poly(I:C)-induced gene expression
profiles of both upper and lower airway epithelium of
patients with asthma, allergic rhinitis and healthy
controls. The transcriptional response to poly(I:C) was
characterized by a strong induction of genes. Among
these genes were those involved in the response to
virus, apoptotic processes and antigen presentation.
Although the majority of genes involved in the response
to poly(I:C) were similarly induced in upper and lower
airways in all groups, we also observed differential expres-
sion, in particular with regard to impaired interferon
expression in asthma. Furthermore, in contrast to healthycontrols and rhinitis patients, the upper and lower airways
of patients with asthma did not show poly(I:C)-induced
down-regulation of mitochondrial genes. These findings
are indicative of mitochondrial dysfunction in airway
epithelium of patients with allergic asthma, and identify
genes that may play a role in the altered viral response
of diseased upper as well as lower airway epithelium.
To our knowledge, this is the first study that extensively
profiles gene expression by microarray of the combined
upper and lower airways epithelium in response to dsRNA
of healthy individuals and patients with allergic rhinitis
with or without allergic asthma. In our earlier study we
describe the differences in gene expression profiles at
baseline levels [11]. Interestingly, differential expression
between the groups is mainly observed in both upper
and lower airways, resulting in primarily comparable
responses to dsRNA infection by the upper and lower
airway epithelium within subjects. Furthermore, only
small differences are observed between healthy controls
and allergic rhinitis patients. Apparently, a pre-existing
inflammatory background in allergic rhinitis does not
grossly affect the response to poly(I:C). This suggests
that the inflammatory pathways as induced by allergens
and rhinovirus are mostly diverse.















SH3KBP1 9.12 <0.001 5.13 0.027
NME7 6.44 <0.001 2.68 0.031
ERAP1 5.06 <0.001 3.76 0.026
MFI2 5 <0.001 3.39 0.042
UBASH3B 3.45 <0.001 2.4 0.042
NSD1 3.11 0.001 2.31 0.034
SLC23A2 −3.55 <0.001 −2.22 0.037
ARHGAP5 −3.57 <0.001 −2.12 0.039
ATP6V0A2 −3.79 <0.001 −2.57 0.03
ANKH −3.96 <0.001 −2.48 0.03
WWTR1 −4.03 <0.001 −2.41 0.048
NEBL −4.69 0.001 −3.75 0.039
MYO5A −4.76 <0.001 −2.67 0.033
LAMP2 −5.02 <0.001 −3.05 0.035
AHNAK −5.02 <0.001 −3.33 0.031
RAB22A −5.93 <0.001 −3.18 0.031
PPAT −6.37 <0.001 −2.72 0.044
TFRC −9.93 <0.001 −5.63 0.028
CCNB2 −15.44 <0.001 −5.37 0.04
IQCG 4.48 0.012 1.07 0.6 In patients with
allergic rhinitis
BBS1 −3.23 <0.001 −1.05 0.8
RBM8A −1.7 0.07 −3.01 0.039 In patients with
allergic rhinitis
with asthmaSSR1 −2.38 0.2 −3.74 0.044
CLN8 −2.53 0.06 −5.34 0.028
FC = fold change; p-value = p-value adjusted for multiple testing.
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inflammatory responses in the airway epithelium in all
three groups extends previous results. In a previous study
examining the transcriptional response of RV-infected pri-
mary bronchial epithelial cells, pro-inflammatory pathways
were similarly induced in asthma and controls [7]. Our
data show that this also holds for allergic rhinitis. Hence,
according to these results, the majority of inflammatory
genes in epithelial cells are induced by viruses in both
the healthy and diseased states. However, this can not
be extrapolated to COPD, in which bronchial epithelial
cells demonstrated enhanced pro-inflammatory and anti-
viral reactions to RV as compared to healthy controls [21].
Still, we also observed several interferon related genes
that were induced in healthy controls and rhinitis patients,
though not in asthma patients (especially the lower
airways). Interferon-β1 (IFNB1) was significantly up-
regulated in all cultures of all groups except for the
lower airways of asthma patients. IL28B, known asinterferon-λ3, was also significantly induced in both
upper and lower airways of allergic rhinitis patients and
controls, though not in asthma patients. This impaired
induction in asthma was not due to high baseline gene
expression prior to stimulation. IFN-βs and IFN-λs play
a major role in the host defense against respiratory viral
infections [8,22]. These results confirm and extend previ-
ous studies on RV-infected primary bronchial epithelial
cells, demonstrating reduced IFN-β [9] and IFN-λ [8] re-
sponse in asthma, suggesting a higher susceptibility to viral
infections and thereby to exacerbations. This may partly
explain the high correlation between viral respiratory tract
infections and asthma exacerbations [1]. Nevertheless,
when considering the most highly up-regulated genes, a
considerable proportion of interferon-related genes ap-
pear to be induced in all groups. This fits in with very
recent data in human bronchial smooth muscle cells,
also showing production of IFNs by poly(I:C) [23]. Not-
ably, the upregulation of these interferon-related genes
tends to be much less in patients with asthma, although a
larger fold change difference of a gene might not necessar-
ily be linked to larger impact on a protein pathway.
The loss of mitochondrial and other metabolic gene
down-regulation to dsRNA in asthma as compared to
healthy controls and allergic rhinitis is in keeping with
previously reported modifications in mitochondrial/meta-
bolic function in A549 cells and animal models of allergic
inflammation. These studies demonstrated that mito-
chondrial dysfunction exacerbates antigen-driven allergic
airway inflammation by increased generation of reactive
oxygen species (ROS), which induces oxidative stress in
the lungs [24]. Environmental factors such as allergens,
ozone, and viruses increase ROS production thereby inter-
actively promoting allergic inflammation [25,26]. Second,
since viral replication is dependent on host resources,
down-regulation of mitochondrial function in a healthy
state may prevent energy production to provide this repli-
cation. A recent review describes previous studies that
have observed modulation of mitochondrial functions
during different viral infections [27]. That viral replication
depends on mitochondrial biogenesis was previously
observed during Human Cytomegalovirus infection [28].
Interestingly, this loss of down-regulated genes in our
study was observed in both upper and lower airways of
patients with asthma, suggesting changed host charac-
teristics of the upper airways in patients with allergic
rhinitis plus asthma as compared to those with allergic
rhinitis alone. This implies at least an interaction between
asthma and rhinitis in the response to respiratory viruses.
Since we did not include asthma patients without allergic
rhinitis we can only speculate about the role of the
presence of allergic rhinitis in asthma. However, in our
previous study we found a large impact of allergic rhinitis
on the differences in epithelial gene expression between















MB 8.95 0.005 2.73 0.017
MAMDC2 3.2 0.009 1.58 0.06
XRCC6BP1 −2.01 0.005 −3.06 0.01
C4orf32 −3.06 0.027 −1.36 0.018
MPPE1 −3.31 0.016 −3.83 0.026
NEBL −3.8 0.009 −3.35 0.012
GPC6 −5.11 0.001 −2.31 0.022
CYP1B1 −6.31 0.027 −2.39 0.027
CLN8 −6.39 0.001 −5 0.011
SHISA2 4.61 0.015 1.29 0.4 In patients with
allergic rhinitis
S100A7A 4.07 0.017 1.38 0.4
NPFFR2 3.7 0.043 1.26 0.2
RDH10 3.37 0.016 1.1 0.6
BMP6 3.36 0.015 1.11 0.6
RNF141 −3.04 0.005 1.08 0.3
C12orf28 −3.08 0.037 −1.14 0.4
LOC148189 −3.23 0.023 −1.13 0.4
CRNN −3.75 0.021 −1.07 0.9
PCK2 −4.16 0.024 −1.25 0.2
CTH −5.08 0.046 −1.23 0.4
FLG −5.17 0.004 −1.53 0.2
FANCD2 1.03 0.2 −3.03 0.014 In patients with
allergic rhinitis
with asthmaMYLK −1.03 0.5 −3.1 0.005
SSR1 −1.16 0.4 −3.13 0.025
FC = fold change; p-value = p-value adjusted for multiple testing.
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well [11]. Therefore, we assume that allergic rhinitis affects
both upper and lower epithelial responses to viruses in
patients with asthma. This would further explain mainly
similar responses to dsRNA by both nasal and bronchial
epithelium within subject-groups.
Among the disease-specific genes that were induced in
allergic rhinitis patients with or without asthma but not
in healthy controls, there were genes (ERAP1, LAMP2)
that have been shown to be involved in antigen presen-
tation [29,30]. Furthermore, several genes (SH3KBP1,
CRNN, FLG, S100A7A) related to allergic inflammation
[31-34] were either induced in allergic rhinitis patients
with or without asthma (SH3KB1) or in allergic rhinitis
patients only (CRNN, FLG, S100A7A). The genes BMP6,
CFB and MYLK have previously been associated with
airway inflammation and hyperresponsiveness [35-37].
Of these genes, CFB was induced in all patients, whereas
BMP6 solely in allergic rhinitis patients and MYLK inallergic rhinitis patients with asthma. The AHNAK gene,
induced in allergic rhinitis patients with or without
asthma, was previously associated with asthma suscep-
tibility [38]. Interestingly, there was also induction of
ciliary genes (BBS1, NEBL, NME7) [39-41] of which
NEBL and NME7 in allergic rhinitis patients with or
without asthma while BBS1 exclusively in patients with
allergic rhinitis. Mucociliary clearance is essential for
the pulmonary defense [42], and ciliary dysfunction has
been previously related to asthma severity [43].
The strength of our study is that we have collected pri-
mary epithelial cells from both upper and lower airways
from the same individuals in three different conditions
(healthy, allergic rhinitis, allergic rhinitis and asthma).
Furthermore, we were able to extensively analyse gene
expression by using microarray, which was confirmed by
PCR analysis. Nevertheless, the study has some limitations.
Firstly, we included relatively few individuals per group.
We carefully calculated this samples size by setting the
false-discovery rate at approximately 5%. A larger sample
size would have allowed capturing smaller differences
in expression profile or greater differences in genes that
display a large variation in expression per individual. As a
consequence we purposely focused on paired differences
before and after poly(I:C) stimulation instead of com-
paring unpaired expression between the different subject
groups. In addition to the original power calculation
mentioned, the statistics used to measure differential
expression applied the Benjamini and Hochberg adjustment
of p-values for multiple testing. This correction uses a
smaller significance level, inevitably reducing the power of
the analysis. This will have led to false-negative results on
poly(I:C)-induced genes, but it purposely limited the risk
of false positive discovery.
We did not use a real virus as a stimulus, but we used
poly(I:C) instead. Although a real virus such as RV would
have been preferable, in order to match the in vivo condi-
tions, dsRNA is an adequate surrogate marker for RV.
Toll-like receptor 3 (TLR3) is required for the sensing
of RV produced dsRNA [10] and the TLR3 ligand poly
(I:C) was found previously to be a very effective stimulus
of airway epithelial cells [44,45]. Since actual steroid ex-
posure will change the expression of many genes, patients
were prohibited steroid usage for 4 weeks before sampling.
In fact, all allergic rhinitis patients were entirely steroid
naïve and only one asthma patient used topical steroids
and one asthma patient used inhaled steroids 4 weeks
prior to recruitment. We cannot exclude carry-over effects
of steroids even over this time span. Finally, culturing of
cells will affect gene expression levels since conditions
are no longer the same as in the airways. This seems to be
inevitable. Alternative procedures to obtain epithelial cells
such as laser capture or direct measurement after isolation
might mitigate these effects of cell culturing, but will
Wagener et al. Respiratory Research 2014, 15:9 Page 8 of 9
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other cell types and/or the (enzymatic) isolation proce-
dures themselves. However, as we compared epithelial
cells from the same individuals, the standardized culturing
of these cells should have affected nose and bronchial
epithelial cells similarly.
The currently observed disease-related differences in
viral-induced gene expression of upper and lower airways
between patients with allergic rhinitis and asthma and
healthy controls may have clinical implications. First, these
results help to understand the mechanistic pathways of
the mutual interaction between asthma and rhinitis, for
which there is considerable clinical evidence [46]. Second,
the current analysis identified several new genes whilst
confirming other genes from previous findings. This may
provide potential targets with respect to mitochondrial
dysfunction and interferon involved genes for drug-dis-
covery studies and for treatment of exacerbations in
patients with combined upper and lower airway disease.Conclusions
In conclusion, we demonstrated that there are differences
between rhinitis patients with and without asthma in the
epithelial expression of dsRNA-induced genes, which are
related to interferons and mitochondrial function. This
appears to be manifested in both the upper and lower
airways, suggesting mainly comparable responses to dsRNA
infection in upper and lower airway epithelium within
subjects. These data identify host-virus interactions in
asthma, rhinitis and controls, which is required for devel-
oping targeted preventative and therapeutic interventions
in asthma exacerbations.Additional files
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